IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,200,877 | -22.8% | 263,929 | +19.5% | 0.00% | 0.0% |
| Q2 2023 | $1,554,798 | +54.5% | 220,852 | +34.1% | 0.00% | 0.0% |
| Q1 2023 | $1,006,238 | -2.4% | 164,687 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $1,030,841 | -32.4% | 163,247 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $1,525,957 | -13.5% | 159,821 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $1,764,264 | +2.3% | 161,200 | +56.0% | 0.00% | 0.0% |
| Q1 2022 | $1,725,103 | -19.0% | 103,303 | +45.2% | 0.00% | -50.0% |
| Q1 2020 | $2,130,000 | +17.1% | 71,140 | +8.3% | 0.00% | 0.0% |
| Q4 2019 | $1,819,000 | +49.0% | 65,705 | -3.2% | 0.00% | +100.0% |
| Q3 2019 | $1,221,000 | -26.9% | 67,863 | -0.4% | 0.00% | -50.0% |
| Q2 2019 | $1,671,000 | +164.0% | 68,138 | +2.3% | 0.00% | +100.0% |
| Q1 2019 | $633,000 | +22.2% | 66,621 | +13.8% | 0.00% | 0.0% |
| Q4 2018 | $518,000 | -11.6% | 58,566 | +12.4% | 0.00% | 0.0% |
| Q3 2018 | $586,000 | -22.6% | 52,126 | -11.8% | 0.00% | 0.0% |
| Q2 2018 | $757,000 | -14.9% | 59,109 | +12.2% | 0.00% | 0.0% |
| Q1 2018 | $890,000 | +142.5% | 52,660 | +14.9% | 0.00% | – |
| Q4 2017 | $367,000 | +16.1% | 45,817 | +12.6% | 0.00% | – |
| Q3 2017 | $316,000 | +2.6% | 40,707 | -2.7% | 0.00% | – |
| Q2 2017 | $308,000 | – | 41,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |